Travel Vaccines Market - Global Industry Analysis and Forecast 2015 - 2021

Travel Vaccines Market - Global Industry Analysis and

Forecast 2015 - 2021

Persistence Market Research

Travel Vaccines Market - Global Industry

Analysis and Forecast 2015 - 2021

Persistence Market Research

1

Travel Vaccines Market - Global Industry Analysis and

Forecast 2015 - 2021

Persistence Market Research Released New Market Report on “Travel Vaccines Market Global Industry Analysis and Forecast 2015 - 2021”.

Health related complications are greater in developing countries and rural areas because of dissimilarities

in sanitary conditions, available food and water bases. The immunization Practices Advisory Committee of

the Center for Disease Control and Prevention (CDC) mentions that travelers should be up-to-date on

routine immunizations, irrespective of travel plans. The target population for the travel vaccines market

include outbound travelers. The travel vaccines for the prevention of hepatitis A, hepatitis B, yellow fever,

tetanus, poliomyelitis, meningococcal disease, typhoid fever are manufactured by leading market players

namely Sanofi Pasteur, Merck, Novartis and GlaxoSmithKline. Among these aforementioned companies,

Sanofi Pasteur and GSK are the notable players in the travel vaccines market that accounts for

approximately 85% of total market. Recently in March 2014, Sanofi Pasteur, the vaccines segment of

Sanofi announced its long term strategic collaboration with SK Chemicals Company to develop

pneumococcal conjugate vaccine (PCV).

Request Full TOC: http://www.persistencemarketresearch.com/toc/5753

The driving factors for the growth of this market include increase in awareness about vaccine preventable

diseases and rise in global travel traffic. Moreover, innovation of novel vaccine technologies and

technological advancements towards molecular genetics is further boosting the growth of market in

coming years. However, requirement of expertise for the production of vaccines and unfavorable

healthcare funding towards vaccination could pose a...